In contrast, except for a single patient, percentages and expression levels of CD24 on CLL cells were significantly increased from BL at 12-month RE in the IBR treatment cohort (Figure 1E, p=0.0105). The gene discussed is CD24; the disease is B-cell chronic lymphocytic leukemia.